Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Instead of maintaining the maximum dose indefinitely, the therapy is used in phases: The theoretical benefits include: maximizing fat loss during the active phase reducing long-term exposure minimizing chronic side effects However, this strategy is still largely experimental and requires further research
Your pituitary gland still controls the release, which means your body maintains its feedback mechanisms and reduces the risk of excess growth hormone levels
This consistency means the vial spends a predictable, minimal amount of time outside the refrigerator during each use
Novo also reported in early 2026 that CagriSema showed superior HbA1c reduction and weight loss vs semaglutide in a Phase 3 diabetes program (REIMAGINE 2)
